Ensign Peak Advisors, Inc Novavax Inc Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Novavax Inc stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 44,900 shares of NVAX stock, worth $380,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares

44,900

Previous 44,900 -0.0%

Holding current value

$380,303

Previous $568,000 0.18%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.89 - $20.97 $5,057 - $27,261	1,300 Added 2.98%	44,900 $568,000
Q1 2024 May 14, 2024	SELL	$3.76 - $6.02 $8,272 - $13,243	-2,200 Reduced 4.8%	43,600 $208,000
Q4 2023 Feb 14, 2024	BUY	$4.8 - $7.67 $5,520 - $8,820	1,150 Added 2.58%	45,800 $219,000
Q3 2023 Nov 13, 2023	BUY	$6.81 - $9.74 $304,066 - $434,891	44,650 New	44,650 $323,000
Q3 2022 Nov 14, 2022	BUY	$18.2 - $76.12 $323,505 - $1.35 Million	17,775 Added 34.47%	69,335 $1.26 Million
Q2 2022 Aug 12, 2022	BUY	$36.28 - $75.29 $244,527 - $507,454	6,740 Added 15.04%	51,560 $2.65 Million
Q1 2022 May 16, 2022	BUY	$69.73 - $142.9 $1.08 Million - $2.2 Million	15,420 Added 52.45%	44,820 $3.3 Million
Q4 2021 Feb 11, 2022	BUY	$134.56 - $217.97 $1.72 Million - $2.78 Million	12,765 Added 76.74%	29,400 $4.21 Million
Q3 2021 Nov 12, 2021	BUY	$177.8 - $270.58 $1.11 Million - $1.69 Million	6,231 Added 59.89%	16,635 $3.45 Million
Q2 2021 Aug 13, 2021	BUY	$121.0 - $257.67 $169,400 - $360,738	1,400 Added 15.55%	10,404 $2.21 Million
Q1 2021 May 12, 2021	SELL	$112.98 - $319.93 $684,771 - $1.94 Million	-6,061 Reduced 40.23%	9,004 $1.63 Million
Q4 2020 Feb 12, 2021	SELL	$78.74 - $139.5 $2.21 Million - $3.92 Million	-28,066 Reduced 65.07%	15,065 $1.68 Million
Q3 2020 Nov 12, 2020	BUY	$79.44 - $178.51 $3.43 Million - $7.7 Million	43,131 New	43,131 $4.67 Million

Others Institutions Holding NVAX

# of Institutions

292

Shares Held

93.4M

Call Options Held

6.95M

Put Options Held

9.4M

View Full List

About NOVAVAX INC

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

More about NVAX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Novavax Inc Transaction History